2025-07-19 - Analysis Report
Okay, here's an analysis of Merck & Co Inc (MRK) based on the provided data.

## Merck & Co Inc (MRK) Stock Analysis

**Company Overview:** Merck & Co Inc is a global pharmaceutical company that develops and manufactures medicines and vaccines.

### 1. Performance vs. S&P 500 (VOO)

*   **MRK Cumulative Return:** -4.12%
*   **VOO Cumulative Return:** 96.72%
*   **Absolute Deviation:** -97.2%
*   **Relative Deviation:** 1.9%

**Analysis:** MRK has significantly underperformed the S&P 500 (VOO) over the period examined. The absolute deviation is substantial (-97.2%). The relative deviation of 1.9% suggests that MRK's underperformance is near the lowest end of its historical range compared to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR     | MDD      | Alpha     | Beta  | Cap(B) |
| ---------- | -------- | -------- | --------- | ----- | ------ |
| 2015-2017  | 5.0%     | 58.2%    | -24.0%    | -0.0  | 134.8  |
| 2016-2018  | 43.0%    | 66.4%    | 25.0%     | -0.1  | 183.1  |
| 2017-2019  | 40.0%    | 66.4%    | 11.0%     | 0.3   | 217.9  |
| 2018-2020  | 20.0%    | 66.4%    | 0.0%      | 0.3   | 196.0  |
| 2019-2021  | -1.0%    | 65.6%    | -50.0%    | 0.3   | 192.4  |
| 2020-2022  | 13.0%    | 69.5%    | 11.0%     | 0.3   | 278.6  |
| 2021-2023  | 31.0%    | 69.5%    | 13.0%     | 0.3   | 273.8  |
| 2022-2024  | -7.0%    | 69.5%    | -33.0%    | 0.2   | 249.8  |
| 2023-2025  | -56.0%   | 61.4%    | -105.0%   | 0.5   | 200.8  |

*   **CAGR Trends:** CAGR is highly variable, with significant declines in the most recent periods.
*   **MDD:** Maximum Drawdown is high, consistently above 50%, indicating substantial risk.
*   **Alpha:** Alpha is predominantly negative, especially recently, indicating underperformance relative to its risk-adjusted benchmark.
*   **Beta:** Beta is generally low, suggesting lower sensitivity to market movements. However, it has increased to 0.5 recently.
*   **Capitalization:** Capitalization has fluctuated but remains high.

### 2. Recent Stock Price Movements

*   **Current Price:** 79.96
*   **Previous Close:** 81.52
*   **Change:** -1.91
*   **5-Day Moving Average:** 81.82
*   **20-Day Moving Average:** 81.318
*   **60-Day Moving Average:** 79.819

**Analysis:** The current price is below both the 5-day and 20-day moving averages, suggesting a short-term downtrend. However, the price is slightly above the 60-day moving average, indicating potential support. The recent negative change suggests bearish momentum.

### 3. Market Risk Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.3399 (Low Risk)
*   **RSI:** 52.93
*   **PPO:** -0.261
*   **Hybrid Signal:** cash\_0% Buy 80% of cash (2 shares - Caution - MRI:0.33)
*   **Delta Relative Deviation (20-day):** -0.2 (Short-term decline)
*   **Expected Return:** -568.1%

**Analysis:**

*   **MRI:** The MRI suggests low market risk.
*   **RSI:** RSI is neutral, indicating neither overbought nor oversold conditions.
*   **PPO:** The negative PPO suggests a short-term downtrend.
*   **Hybrid Signal:** The signal recommends buying a small amount of the stock but with caution due to the MRI.
*   **Delta Relative Deviation:** The negative change in relative deviation confirms the recent underperformance.
*   **Expected Return:** The extremely negative expected return is concerning and suggests a very unfavorable long-term outlook compared to the S&P 500.
*   **Price Change Impact:** The recent price change of -1.91, while not extreme, contributes to the overall negative sentiment, reinforcing the short-term downtrend.

### 4. Recent News & Significant Events

*   **[2025-07-18]:** Major business developments, regulatory changes, or market events affecting Merck & Co Inc.
*   **[2025-07-19]:** Analysts discussing Merck & Co Inc's recent performance and outlook.
*   **[2025-07-17]:** Merck & Co Inc's stock showing notable volatility.
*   **[2025-07-16]:** Market experts highlighting both risks and opportunities for Merck & Co Inc.

**Analysis:** Recent news indicates significant events, analyst discussions, and stock volatility. This suggests a dynamic environment with potential risks and opportunities. Monitoring company announcements and news is crucial.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출        |
| ---------- | ---- | ----------- |
| 2025-05-02 | 2.01 | 15.53 B$    |
| 2024-11-06 | 1.25 | 16.66 B$    |
| 2024-08-05 | 2.15 | 16.11 B$    |
| 2024-05-03 | 1.88 | 15.78 B$    |
| 2025-05-02 | 1.88 | 15.78 B$    |

**Analysis:**
*   **EPS:** EPS values have fluctuated, with the most recent value being 1.88.
*   **Revenue:** Revenue has been relatively stable, ranging from 15.53 B$ to 16.66 B$. The latest value is 15.78 B$.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
| ---------- | --------- | ------------- |
| 2025-03-31 | $15.53B   | 77.98%        |
| 2024-12-31 | $15.62B   | 75.50%        |
| 2024-09-30 | $16.66B   | 75.51%        |
| 2024-06-30 | $16.11B   | 76.76%        |
| 2024-03-31 | $15.78B   | 77.56%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE     |
| ---------- | --------- | ------- |
| 2025-03-31 | $48.34B   | 10.51%  |
| 2024-12-31 | $46.31B   | 8.08%   |
| 2024-09-30 | $44.50B   | 7.09%   |
| 2024-06-30 | $43.58B   | 12.52%  |
| 2024-03-31 | $40.36B   | 11.80%  |

**Analysis:**

*   **Revenue:** Revenue has been fairly consistent across the quarters.
*   **Profit Margin:** Profit margins are high and relatively stable.
*   **Equity:** Equity has been generally increasing.
*   **ROE:** ROE has fluctuated, with the latest value at 10.51%.

### 7. Overall Summary

*   **Underperformance:** MRK has significantly underperformed the S&P 500, with a negative expected return.
*   **Recent Price Action:** Recent price declines and negative short-term indicators suggest bearish momentum.
*   **Financial Health:** Revenue and profit margins remain strong.
*   **Market Environment:** Recent news suggests a dynamic environment with potential risks and opportunities.
*   **Investment Recommendation:** Based on the provided data, a cautious approach is warranted. The Hybrid Signal suggests buying a small amount, but the significantly negative expected return and recent underperformance raise concerns. Continuous monitoring of company-specific news, earnings, and market conditions is crucial.

